<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> (NO) produced by inducible NO synthase contributes to ischemic brain damage </plain></SENT>
<SENT sid="1" pm="."><plain>However, the role of inducible NO synthase-derived NO on neonatal hypoxic-ischemic <z:hpo ids='HP_0001298'>encephalopathy</z:hpo> has not been clarified </plain></SENT>
<SENT sid="2" pm="."><plain>We demonstrate here that <z:chebi fb="0" ids="40618">aminoguanidine</z:chebi>, a relatively selective inhibitor of inducible NO synthase, ameliorated neonatal hypoxic-ischemic brain damage and that temporal profiles of NO correlated with the neuroprotective effect of <z:chebi fb="0" ids="40618">aminoguanidine</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>Seven-day-old Wister rat pups were subjected to left carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> followed by 2.5 h of hypoxic exposure (8% oxygen) </plain></SENT>
<SENT sid="4" pm="."><plain><z:mpath ids='MPATH_124'>Infarct</z:mpath> volumes (cortical and striatal) were assessed 72 h after the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:mp ids='MP_0005039'>hypoxia</z:mp>-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> by planimetric analysis of coronal brain slices stained with <z:chebi fb="1" ids="51686">hematoxylin</z:chebi>-eosin </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="0" ids="40618">Aminoguanidine</z:chebi> (300 mg/kg i.p.), administered once before the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:mp ids='MP_0005039'>hypoxia</z:mp>-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and then three times daily, significantly ameliorated <z:mpath ids='MPATH_124'>infarct</z:mpath> volume (89% reduction in the cerebral cortex and 90% in the striatum; p&lt;0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>NO metabolites were measured by means of chemiluminescence using an NO analyzer </plain></SENT>
<SENT sid="7" pm="."><plain>In controls, there was a significant biphasic increase in NO metabolites in the ligated side at 1 h (during <z:mp ids='MP_0005039'>hypoxia</z:mp>) and at 72 h after the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:mp ids='MP_0005039'>hypoxia</z:mp> (p&lt;0.05) </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="0" ids="40618">Aminoguanidine</z:chebi> did not suppress the first peak but significantly reduced the second one (p&lt;0.05), and markedly reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> size in a neonatal ischemic rat model </plain></SENT>
<SENT sid="9" pm="."><plain>Suppression of NO production after reperfusion is a likely mechanism of this neuroprotection </plain></SENT>
</text></document>